Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Equity (2016 - 2025)

Historic Return on Equity for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to 0.95%.

  • Regenxbio's Return on Equity fell 2100.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.95%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 0.79% for FY2024, which is 1600.0% down from last year.
  • As of Q3 2025, Regenxbio's Return on Equity stood at 0.95%, which was down 2100.0% from 0.72% recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Return on Equity ranged from a high of 0.21% in Q4 2021 and a low of 0.95% during Q3 2025
  • Its 5-year average for Return on Equity is 0.46%, with a median of 0.59% in 2025.
  • Per our database at Business Quant, Regenxbio's Return on Equity skyrocketed by 5600bps in 2022 and then crashed by -8000bps in 2023.
  • Over the past 5 years, Regenxbio's Return on Equity (Quarter) stood at 0.21% in 2021, then plummeted by -349bps to 0.52% in 2022, then plummeted by -51bps to 0.78% in 2023, then fell by -4bps to 0.81% in 2024, then dropped by -17bps to 0.95% in 2025.
  • Its Return on Equity was 0.95% in Q3 2025, compared to 0.72% in Q2 2025 and 0.59% in Q1 2025.